Buy now, pay later (BNPL) credit can now be used to pay for weight-loss medicines. This comes as a new doctor-led programme tries to make sought-after GLP-1 drugs more affordable. Obiflex offers virtual consultations with doctors who can prescribe the medicines. Furthermore, it lets patients spread their monthly treatment cost over instalments. How the buy now, pay later offer works…
Tag: weight-loss drugs
-
Aspen Pharmacare Earnings Jump 22% on Mounjaro Demand
Aspen Pharmacare earnings surged in its latest financial year, with normalised headline earnings per share climbing 22% on the back of booming demand for weight-loss medicines. Africa’s largest drugmaker reported the rise on Wednesday for the year ending 30 June. The standout driver was Eli Lilly’s Mounjaro, which Aspen promotes and sells across South Africa and other Sub-Saharan African markets…
-
Illicit Medicines In South Africa Spark Sahpra Crackdown
The availability of illicit medicines in South Africa is increasing, according to the South African Health Products Regulatory Authority. Sahpra regulates medicines and medical devices in the country. It said reports from consumers and seizures by inspectors suggest the problem is widespread. Criminal syndicates are targeting widely used or in-demand medicines. These include weight-loss drugs, antibiotics, painkillers and medicines used…
-
Telehealth GLP-1 Prescribing Sparks Safety Fears
A Yale University study has identified serious weaknesses in how some telehealth providers prescribe GLP-1 weight-loss medications. The secret shopper study examined 49 online healthcare providers. Researchers used a fictional patient who met the clinical criteria for GLP-1 treatment. The findings suggest that several virtual clinics may be prioritising fast access to prescriptions over detailed medical care. This could expose…
-
Aspen Targets Mounjaro Expansion in Africa Following Approval
Aspen targeting Mounjaro expansion will bring the high-demand drug Mounjaro to Sub-Saharan Africa. Mounjaro is also known as tirzepatide. Launches across the continent are anticipated in 2026. CEO Stephen Saad confirmed this plan. He announced it in his annual letter to shareholders. The move follows major success in South Africa. It also comes after a new regulatory approval. This approval…
-
Healthcare Costs Rise with Ozempic and Wegovy
A new study has found that while weight-loss drugs like Ozempic and Wegovy significantly improve health, they are also linked to a sustained increase in spending on other medical care. The study, led by Yale economics professor Jason Abaluck and published in JAMA Network Open, confirms that semaglutide (the active ingredient in Wegovy and Ozempic) effectively reduces weight, blood pressure,…